checkpoint inhibitors (Immune Design)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namecheckpoint inhibitors (Immune Design)
Drug Alias Namecancer therapeutic vaccines (ID-LV + GLA adjuvant) (Immune Design)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionToll like receptor 4 agonists
TargetsToll like receptor 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Design Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Design Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A